3/4
06:16 am
dsnky
Esperion to acquire Corstasis for cardiovascular franchise expansion [Yahoo! Finance]
Low
Report
Esperion to acquire Corstasis for cardiovascular franchise expansion [Yahoo! Finance]
3/3
10:05 am
dsnky
Antibody-drug Conjugates (ADCs) in Oncology Market Competitive Landscape Report 2026: Comprehensive Insights About 200+ Companies and 220+ Drugs by Product Type, Stage, and Route of Administration [Yahoo! Finance]
Low
Report
Antibody-drug Conjugates (ADCs) in Oncology Market Competitive Landscape Report 2026: Comprehensive Insights About 200+ Companies and 220+ Drugs by Product Type, Stage, and Route of Administration [Yahoo! Finance]
3/3
08:23 am
dsnky
CellCarta Appoints Ehab A. El-Gabry, MD, as Chief Medical Officer & Head of Companion Diagnostics to Advance CDx Strategy, Digital Pathology and AI [Yahoo! Finance]
Medium
Report
CellCarta Appoints Ehab A. El-Gabry, MD, as Chief Medical Officer & Head of Companion Diagnostics to Advance CDx Strategy, Digital Pathology and AI [Yahoo! Finance]
2/27
07:38 am
dsnky
What Daiichi Sankyo Company (TSE:4568)'s ENHERTU EMA Filing and AI Oncology Push Mean For Shareholders [Yahoo! Finance]
Low
Report
What Daiichi Sankyo Company (TSE:4568)'s ENHERTU EMA Filing and AI Oncology Push Mean For Shareholders [Yahoo! Finance]
2/19
07:00 pm
dsnky
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
Low
Report
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
2/19
02:30 am
dsnky
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer
Low
Report
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer
2/17
08:02 am
dsnky
BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal Analytics [Yahoo! Finance]
Medium
Report
BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal Analytics [Yahoo! Finance]
2/4
07:00 am
dsnky
DS3790 Enters Clinical Development as First DXd ADC in Hematology from Industry-Leading ADC Portfolio of Daiichi Sankyo
Low
Report
DS3790 Enters Clinical Development as First DXd ADC in Hematology from Industry-Leading ADC Portfolio of Daiichi Sankyo
2/3
08:23 am
dsnky
Astra wins FDA priority review for Daiichi's Datroway; denied approval for lupus therapy [Seeking Alpha]
Low
Report
Astra wins FDA priority review for Daiichi's Datroway; denied approval for lupus therapy [Seeking Alpha]
2/3
02:30 am
dsnky
DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy
Low
Report
DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy
2/1
11:44 pm
dsnky
Banking on the long-term potential of oncology drugs: Daiichi Sankyo CFO [CNBC]
Medium
Report
Banking on the long-term potential of oncology drugs: Daiichi Sankyo CFO [CNBC]
1/26
01:33 am
dsnky
Promising New Weight-Loss Pill From South Korea’s Sam Chun Dang Pharm Mints Country’s Newest Billionaire [Forbes]
Low
Report
Promising New Weight-Loss Pill From South Korea’s Sam Chun Dang Pharm Mints Country’s Newest Billionaire [Forbes]
1/22
02:30 am
dsnky
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe [Yahoo! Finance]
Low
Report
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe [Yahoo! Finance]
1/22
01:30 am
dsnky
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe
Low
Report
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe
1/21
02:02 pm
dsnky
Daiichi Sankyo opens Toronto headquarters to fuel Canadian oncology growth [Yahoo! Finance]
Neutral
Report
Daiichi Sankyo opens Toronto headquarters to fuel Canadian oncology growth [Yahoo! Finance]
1/21
08:39 am
dsnky
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology [Yahoo! Finance]
Low
Report
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology [Yahoo! Finance]
1/21
08:14 am
dsnky
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology [Globe and Mail, The (Toronto, Canada)]
Low
Report
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology [Globe and Mail, The (Toronto, Canada)]
1/21
08:00 am
dsnky
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
Low
Report
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
1/21
08:00 am
dsnky
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
Low
Report
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
1/21
08:00 am
dsnky
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
Low
Report
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
1/19
02:40 am
dsnky
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer [Yahoo! Finance]
Medium
Report
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer [Yahoo! Finance]
1/19
02:30 am
dsnky
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
Medium
Report
ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
1/13
07:00 am
dsnky
TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
Medium
Report
TROPION-Lung17 TROP2 Biomarker Directed Phase 3 Trial of DATROWAY® Initiated in Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
1/9
03:42 am
dsnky
Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials [Yahoo! Finance]
Low
Report
Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials [Yahoo! Finance]
1/8
01:57 am
dsnky
Organon Enters into a Commercialization Agreement for Daiichi Sankyo's Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway [Yahoo! Finance]
Low
Report
Organon Enters into a Commercialization Agreement for Daiichi Sankyo's Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway [Yahoo! Finance]